Pharmaceutical and Biotechnology Market size will grow at USD 6.5 Tn by 2035; Rising Prevalence of Chronic Diseases is Propelling the Market Expansion

Download Sample

Published Date: May 2025

Pharmaceuticals are medicinal drugs, while biotechnology is the use of biological research to develop products from living organisms. Pharmaceuticals and biotechnology market growth is being driven due to chronic diseases, biologics acceptance, government investment, and advanced therapies. Technological breakthroughs in genomics, proteomics, and bioinformatics are accelerating drug discovery and development. Personalized medicine and AI and machine learning are also contributing to market expansion, enhancing efficiency and addressing unmet medical needs.

Segmentation Analysis:

By Product	Biotechnology and Pharmaceutical
By Age Group	Children & Adolescents, Adults, and Geriatric
By Technology	Nanotechnology, Tissue Engineering & Regeneration, PCR & Sequencing, Artificial Intelligence (AI), Personalized Medicine, and Others
By Therapeutic Application	Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Disease Prevention, Cardiovascular Diseases, Neurological Diseases and Others
By End-User	Pharmaceutical Companies, Biotechnology Companies, Healthcare Providers, Research and Government Institutes, and Others

Report Highlights:

Pharmaceutical and biotechnology market is accounted at USD 3.3 Tn, in 2025.
The target market size is expected to grow at a rate of USD 6.5 Tn, by 2035, and at a CAGR of 7.8%.
Depending on product, the biotechnology segment is anticipated to govern the pharmaceutical and biotechnology market share.
On the basis of age group, the adults segment is projected to rule over the pharmaceutical and biotechnology market.
According to technology, the PCR & sequencing segment is holding the upper hand in the pharmaceutical and biotechnology market.
Based on therapeutic application, the oncology segment is dominating the pharmaceutical and biotechnology market.
Stemming from end user, the pharmaceutical companies are the end user which is influencing the target market.
By region, North America is the region which is attributed to lead the pharmaceutical and biotechnology market share.
Europe is the region which has the pharmaceutical and biotechnology market growing with the highest CAGR, during the forecast period.

Market Dynamics:

Growing Factor	Challenge Factor	Market Trend
Growing Acceptance Of Biologics And Biosimilars	Ethical Concerns Of Pharmaceutical And Biotechnology	Integration Of AI and ML With Pharmaceutical And Biotechnology

Key Highlights:

In May 2024, Boston Micro Fabrication (BMF) had introduced BMF Biotechnology Inc. Headquartered in San Diego, California, BMF Biotechnology Inc. which was dedicated to developing and commercialising innovative BioChips (organ-on-a-chip platforms) through cultivating large-scale tissues in vitro, helping accelerate new drug and cosmetic development.

Report Analysis:

Applications of PEGylated proteins and peptides on pharmaceutical biotechnology:

To improve solubility.
To improve thermal and mechanical stability.
To reduce immunogenicity.
To reduce renal excretion and clearance.
To protect proteins from degradation such as proteolysis.
To optimize pharmacokinetic properties such as increased blood circulation and extend plasma half - lives.

Browse ∼60 market data tables and ∼35 figures through ∼160 slides and in-depth TOC on “Pharmaceutical and Biotechnology Market, By Product (Biotechnology and Pharmaceutical), Age Group (Children & Adolescents, Adults, and Geriatric), Technology (Nanotechnology, Tissue Engineering & Regeneration, PCR & Sequencing, Artificial Intelligence (AI), Personalized Medicine, and Others), Therapeutic Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Disease Prevention, Cardiovascular Diseases, Neurological Diseases and Others), End User (Pharmaceutical Companies, Biotechnology Companies, Healthcare Providers, Research and Government Institutes, and Others), and By Region - Trends, Analysis, and Forecast till 2035”

Segmentation:

By Product:

Biotechnology
- Instrument
- Consumables
Pharmaceutical
- Biologics & Biosimilars (Large Molecules)
  - Monoclonal Antibodies
  - Vaccines
  - Cell & Gene Therapy
  - Others
- Conventional Drugs (Small Molecules)

By Age Group:

Children & Adolescents
Adults
Geriatric

By Technology:

Nanotechnology
Tissue Engineering & Regeneration
PCR & Sequencing
Artificial Intelligence (AI)
Personalized Medicine
Others

By Therapeutic Application:

Oncology
Inflammatory and Infectious Diseases
Autoimmune Disorders
Metabolic Disorders
Hormonal Disorders
Disease Prevention
Cardiovascular Diseases
Neurological Diseases
Others

By End User:

Pharmaceutical Companies
Biotechnology Companies
Healthcare Providers
Research and Government Institutes,
Others

By Region:

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa

For more insights into the Pharmaceutical and Biotechnology Market and its future trends, visit link below: https://www.prophecymarketinsights.com/market_insight/Global-Pharmaceutical-and-Biotechnology-Market-881

Competitive Landscape of Pharmaceutical and Biotechnology Market:

The companies operating in the pharmaceutical and biotechnology market are Novartis AG, GSK plc., Merck KGaA, AstraZeneca, Siemens Healthineers AG, Parexel International (MA) Corporation, Eli Lilly and Company, Aragen Life Sciences Ltd., Pfizer Inc., Johnson & Johnson Services, Inc., Amgen Inc., Genentech, Inc., UCB S.A., and Sai Life Sciences Limited.